THC

THC

USD

Tenet Healthcare Corporation Common Stock

$148.030+2.530 (1.739%)

Preço em tempo real

Healthcare
Medical Care Facilities
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$145.500

Máximo

$149.570

Mínimo

$145.270

Volume

0.21M

Fundamentos da empresa

Capitalização de mercado

13.7B

Setor

Medical Care Facilities

País

United States

Estatísticas de negociação

Volume médio

1.75M

Bolsa de valores

NYQ

Moeda

USD

Faixa de 52 semanas

Mínimo $109.82Atual $148.030Máximo $171.2

Relatório de análise de IA

Última atualização: 2/05/2025
Gerado por IAFonte de dados: Yahoo Finance, Bloomberg, SEC

THC: Tenet Healthcare Corporation Common Stock - What's Driving the Recent Action and What Might Be Next?

Stock Symbol: THC Generate Date: 2025-05-02 23:25:34

Alright, let's break down what's been going on with Tenet Healthcare stock lately. We've got some fresh news, a look at how the price has moved, and even a peek at what an AI model thinks is coming.

Recent News Buzz: Mostly Good Vibes

The news flow around THC has been pretty upbeat in the last few days of April. The biggest splash came from the company itself, reporting some seriously strong numbers for the first quarter of 2025. We're talking net income hitting $406 million, which translates to $4.27 per share. Even better, their adjusted earnings per share jumped a solid 35.4% compared to the same time last year. That's a clear sign the business is performing well right now.

Following those good earnings, a few big investment banks chimed in. Barclays, RBC Capital, and UBS all kept their positive ratings on the stock ("Overweight," "Outperform," and "Buy," respectively). Not only that, but they also raised their price targets. UBS is the most bullish, bumping their target all the way up to $230. RBC went to $189, and Barclays to $171. This tells us that analysts who follow the company closely are feeling more confident about its future value after seeing the latest results.

Now, it wasn't all sunshine. A couple of weeks earlier, back in mid-April, Baird actually downgraded the stock and lowered their price target. But looking at the more recent news, especially the earnings report and the subsequent analyst upgrades, the overall sentiment has definitely swung positive.

Price Check: A Big Jump Lately

Looking at the stock's journey over the last month or so, it's been a bit of a rollercoaster. The price dipped quite a bit through March and into early April, hitting a low around $109.82 on April 21st. Ouch.

But then, something shifted. Right around the time of that strong earnings report (April 29th), the stock saw a significant pop. It jumped from around $128 to over $138 in one day, and it's kept climbing since. The last price we have data for is $148.03 on May 2nd. So, after a rough patch, the stock has seen a sharp move upwards, likely fueled by that positive news.

What about the immediate future? An AI prediction model is forecasting continued upward movement, suggesting a gain of 0.74% today, 2.57% tomorrow, and 4.09% the day after. That aligns with the recent positive momentum.

Putting It Together: Outlook & Ideas

Based on the combination of strong earnings, multiple analysts raising their price targets, the stock's recent upward surge, and the AI's positive short-term forecast, the near-term picture for THC looks quite favorable. It seems the market is reacting positively to the company's performance and the increased confidence from analysts.

What might this suggest? The current situation seems to lean towards favoring potential buyers or those looking to add to their position. The momentum is clearly positive right now.

Potential Entry Consideration: The stock has already made a big move. The AI model suggested potential entry points slightly below the current price, around $146.61 or $147.57. While the price is just above that now, if you're considering getting in, you might look at the current level or perhaps wait for any minor dip back towards that $147-$148 area. The recent price action shows strong buying interest around these levels following the earnings news.

Potential Exit/Stop-Loss Consideration: Managing risk is always key. The AI model gave a very short-term take profit idea at $148.19, which is basically right where the stock is now – maybe useful for super quick trades, but the analyst targets are much higher. Those higher targets ($171, $189, $230) could be seen as potential upside goals over a longer timeframe if the positive trend continues. For a stop-loss, the AI suggested $130.75. This level is well below the recent jump and could serve as a point to reconsider if the positive momentum completely reverses. Setting a stop-loss below the low of the big jump day (around $126.75 on April 29th) could also be a strategy to protect against a breakdown of the recent rally.

Company Context

Just a quick reminder about Tenet Healthcare: they're a big player in the healthcare services world, running hospitals and outpatient centers. So, when they report strong earnings like they just did, it tells us their core business of providing medical care is doing well. While they do carry a good amount of debt (something to be aware of), their recent profitability and return on equity look solid. The positive news and analyst views are directly tied to how well they're executing in their industry.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research or consult with a qualified financial advisor before making any investment decisions.

Notícias relacionadas

Analyst Upgrades

Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $171

Barclays analyst Andrew Mok maintains Tenet Healthcare with a Overweight and raises the price target from $161 to $171.

Ver mais
Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $171
Analyst Upgrades

RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $189

RBC Capital analyst Ben Hendrix maintains Tenet Healthcare with a Outperform and raises the price target from $183 to $189.

Ver mais
RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $189
Analyst Upgrades

UBS Maintains Buy on Tenet Healthcare, Raises Price Target to $230

UBS analyst A.J. Rice maintains Tenet Healthcare with a Buy and raises the price target from $217 to $230.

Ver mais
UBS Maintains Buy on Tenet Healthcare, Raises Price Target to $230
BusinessWire

Tenet Reports Strong First Quarter 2025 Results

Net income available to common shareholders in first quarter 2025 was $406 million, or $4.27 per diluted share Adjusted diluted earnings per share1 increased 35.4% to $4.36 in first quarter 2025 compared to $3.22 in

Ver mais
Tenet Reports Strong First Quarter 2025 Results
Analyst Upgrades

Baird Downgrades Tenet Healthcare to Neutral, Lowers Price Target to $137

Baird analyst Michael Ha downgrades Tenet Healthcare from Outperform to Neutral and lowers the price target from $153 to $137.

Ver mais
Baird Downgrades Tenet Healthcare to Neutral, Lowers Price Target to $137

Previsão de IABeta

Recomendação de IA

Altista

Atualizado em: 4/05/2025, 01:55

BaixistaNeutroAltista

72.2% Confiança

Risco e negociação

Nível de risco3/5
Risco médio
Adequado para
ValorConservadorAgressivo
Guia de negociação

Ponto de entrada

$148.45

Tomar lucro

$158.46

Parar perda

$133.24

Fatores-chave

DMI mostra tendência de baixa (ADX:20.5, +DI:5.5, -DI:6.1), sugerindo cautela
O preço atual está extremamente próximo do nível de suporte ($148.03), sugerindo forte oportunidade de compra
O volume de negociação é 7.1x a média (17,556), indicando pressão de compra extremamente forte
MACD -0.1608 está acima da linha de sinal -0.2017, indicando um crossover de alta

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.